Huiying Gu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Huiying Gu has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
Yansheng Du
Department of Neurology, Indiana University, Indianapolis, Indiana, USA
5 shared publications- Wei Zheng
School of Health Sciences, Purdue University, West Lafayette, USA
3 shared publications - Yansheng Du
Department of Neurology, Indiana University School of Medicine, Indianapolis, IN 46202, USA
3 shared publications Changwei Zhou
Department of Orthopedics, The 2nd Affiliated Hospital of Harbin Medical University, Harbin, 150086, PR China
2 shared publicationsChongyi Sun
Department of Orthopedics, The 2nd Affiliated Hospital of Harbin Medical University, Harbin, 150086, PR China
2 shared publicationsRong Sun
Department of Outpatient OR, The 1st Affiliated Hospital of Harbin Medical University, Harbin, 150086, PR China
2 shared publications
Latest Publications
- Open Access
Pb Induces MCP-1 in the Choroid Plexus
Lead (Pb) is an environmental element that has been implicated in the development of dementia and Alzheimer’s disease (AD). Additionally, innate immune activation contributes to AD pathophysiology. However, the mechanisms involved remain poorly understood. The choroid plexus (CP) is not only the site of cerebrospinal fluid (CSF) production, but also an important location for communication between the circulation and the CSF. In this study, we investigated the involvement of the CP during Pb exposure by evaluating the expression of the monocyte chemoattractant protein-1 (MCP-1). MCP-1 is highly expressed in the CP compared to other CNS tissues. MCP-1 regulates macrophage infiltration and is upregulated in AD brains. Our study revealed that Pb exposure stimulated MCP-1 expression, along with a significantly increased macrophage infiltration into the CP. By using cultured Z310 rat CP cells, Pb exposure stimulated MCP-1 expression in a dose-related fashion and markedly activated both NF-κB and p38 MAP kinase. Interestingly, both SB 203580, a p38 inhibitor, and BAY 11-7082, an NF-κB p65 inhibitor, significantly blocked Pb-induced MCP-1 expression. However, SB203580 did not directly inhibit NF-κB p65 phosphorylation. In conclusion, Pb exposure stimulates MCP-1 expression via the p38 and NF-κB p65 pathways along with macrophage infiltration into the CP.
Open AccessPb Induces MCP-1 in the Choroid Plexus
Lead (Pb) is an environmental element that has been implicated in the development of dementia and Alzheimer’s disease (AD). Additionally, innate immune activation contributes to AD pathophysiology. However, the mechanisms involved remain poorly understood. The choroid plexus (CP) is not only the site of cerebrospinal fluid (CSF) production, but also an important location for communication between the circulation and the CSF. In this study, we investigated the involvement of the CP during Pb exposure by evaluating the expression of the monocyte chemoattractant protein-1 (MCP-1). MCP-1 is highly expressed in the CP compared to other CNS tissues. MCP-1 regulates macrophage infiltration and is upregulated in AD brains. Our study revealed that Pb exposure stimulated MCP-1 expression, along with a significantly increased macrophage infiltration into the CP. By using cultured Z310 rat CP cells, Pb exposure stimulated MCP-1 expression in a dose-related fashion and markedly activated both NF-κB and p38 MAP kinase. Interestingly, both SB 203580, a p38 inhibitor, and BAY 11-7082, an NF-κB p65 inhibitor, significantly blocked Pb-induced MCP-1 expression. However, SB203580 did not directly inhibit NF-κB p65 phosphorylation. In conclusion, Pb exposure stimulates MCP-1 expression via the p38 and NF-κB p65 pathways along with macrophage infiltration into the CP.
- 15 November 2021
- Published by Elsevier in NeuroToxicology
- Vol. 88, 106-115
Distribution of Pb and Se in mouse brain following subchronic Pb exposure by using synchrotron X-ray fluorescence
- 15 November 2021
- Published by Elsevier in NeuroToxicology
- Vol. 88, 106-115
Distribution of Pb and Se in mouse brain following subchronic Pb exposure by using synchrotron X-ray fluorescence
- 27 November 2020
- Published by Wolters Kluwer Health in NeuroReport
- Vol. 32 (1) , 38-43
Minocycline, but not doxycycline attenuates NMDA-induced [Ca2+]i and excitotoxicity
Minocycline and doxycycline, two semisynthetic second-generation tetracyclines, are reported to provide neuroprotection against brain injury and glutamate-induced neurotoxicity in neuronal cultures. Doxycycline has been postulated as the potential ideal candidate for further therapeutic development as it has fewer adverse effects than minocycline. In this study, we determined whether minocycline and doxycycline could similarly protect neurons against excitotoxic insults. We treated cultured rat cortical neurons and cerebellar granule neurons (CGN) with excitotoxic concentrations of NMDA or glutamate in the presence or absence of minocycline or doxycycline. Intracellular Ca2+ concentration ([Ca2+]i) was also measured using a Fluorescent Light Imaging Plate Reader (FLIPR; Molecular Devices) with the calcium sensitive dye Fluo-3 AM. We found that minocycline and tetracycline markedly protected neurons against NMDA- and glutamate-induced neuronal death. In contrast, the structurally related tetracycline, doxycycline, was ineffective at concentrations up to 100 μM. Furthermore, minocycline, but not doxycycline, also significantly attenuated NMDA- or glutamate-induced [Ca2+]i in both cortical neurons and CGN. Our results suggest that minocycline but not doxycycline is able to directly block NMDA- or glutamate-induced excitotoxicity in neurons most likely by inhibiting NMDA- and glutamate-induced [Ca2+]i. This finding may contribute to our understanding of the molecular mechanisms underlying doxycycline- and minocycline-induced neuroprotection.
- 27 November 2020
- Published by Wolters Kluwer Health in NeuroReport
- Vol. 32 (1) , 38-43
Minocycline, but not doxycycline attenuates NMDA-induced [Ca2+]i and excitotoxicity
Minocycline and doxycycline, two semisynthetic second-generation tetracyclines, are reported to provide neuroprotection against brain injury and glutamate-induced neurotoxicity in neuronal cultures. Doxycycline has been postulated as the potential ideal candidate for further therapeutic development as it has fewer adverse effects than minocycline. In this study, we determined whether minocycline and doxycycline could similarly protect neurons against excitotoxic insults. We treated cultured rat cortical neurons and cerebellar granule neurons (CGN) with excitotoxic concentrations of NMDA or glutamate in the presence or absence of minocycline or doxycycline. Intracellular Ca2+ concentration ([Ca2+]i) was also measured using a Fluorescent Light Imaging Plate Reader (FLIPR; Molecular Devices) with the calcium sensitive dye Fluo-3 AM. We found that minocycline and tetracycline markedly protected neurons against NMDA- and glutamate-induced neuronal death. In contrast, the structurally related tetracycline, doxycycline, was ineffective at concentrations up to 100 μM. Furthermore, minocycline, but not doxycycline, also significantly attenuated NMDA- or glutamate-induced [Ca2+]i in both cortical neurons and CGN. Our results suggest that minocycline but not doxycycline is able to directly block NMDA- or glutamate-induced excitotoxicity in neurons most likely by inhibiting NMDA- and glutamate-induced [Ca2+]i. This finding may contribute to our understanding of the molecular mechanisms underlying doxycycline- and minocycline-induced neuroprotection.
- 1 January 2020
- Published by Elsevier in Brain Research Bulletin
- Vol. 154, 102-105
Minocycline protects neurons against glial cells-mediated bilirubin neurotoxicity
- 1 January 2020
- Published by Elsevier in Brain Research Bulletin
- Vol. 154, 102-105
Minocycline protects neurons against glial cells-mediated bilirubin neurotoxicity
- 1 March 2016
- Published by Elsevier in Brain Research Bulletin
- Vol. 121, 241-245
Metformin prevents cerebellar granule neurons against glutamate-induced neurotoxicity
- 1 March 2016
- Published by Elsevier in Brain Research Bulletin
- Vol. 121, 241-245
Metformin prevents cerebellar granule neurons against glutamate-induced neurotoxicity
- 1 January 2015
- Published by Elsevier in Neuroscience Letters
- Vol. 584, 56-59
TIMP1 in conditioned media of human adipose stromal cells protects neurons against oxygen-glucose deprivation injury
- 1 January 2015
- Published by Elsevier in Neuroscience Letters
- Vol. 584, 56-59
TIMP1 in conditioned media of human adipose stromal cells protects neurons against oxygen-glucose deprivation injury
- 1 October 2014
- Published by Elsevier in Neuroscience Letters
- Vol. 581, 98-102
Adipose stem cells-conditioned medium blocks 6-hydroxydopamine-induced neurotoxicity via the IGF-1/PI3K/AKT pathway
- 1 October 2014
- Published by Elsevier in Neuroscience Letters
- Vol. 581, 98-102
Adipose stem cells-conditioned medium blocks 6-hydroxydopamine-induced neurotoxicity via the IGF-1/PI3K/AKT pathway
- 1 September 2012
- Published by Elsevier in Toxicology Letters
- Vol. 213 (2) , 211-219
Increased β-amyloid deposition in Tg-SWDI transgenic mouse brain following in vivo lead exposure
- 1 September 2012
- Published by Elsevier in Toxicology Letters
- Vol. 213 (2) , 211-219
Increased β-amyloid deposition in Tg-SWDI transgenic mouse brain following in vivo lead exposure